An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

Disclosed is a kit including a first container including a composition including at least one antioxidant selenoprotein and at least one second container including at least one composition including at least one oxidant selenocompound. Also disclosed is a method of administration that allows to administer effective and cytotoxic doses of selenocompounds, allowing the inhibition of the hyper-activation of phagocytes and in particular of circulating immature neutrophils and directly and indirectly protects endothelial cells, in particular for the treatment of sepsis, SIRS and leukemia. Further disclosed is an administration device adapted to the administration method.

Articles including a solid porous material having a selenium nanomaterial bound to a surface of and within the solid porous material. The article may be a include no polymeric stabilizer or proteinaceous stabilizer. The solid porous material may be a sponge, a film, a fabric, a non-woven material, or a metal-organic framework (MOF), or a combination thereof. The article may be produced by treating a solid porous material with an aqueous selenous acid solution and heating the solid porous material to form the selenium nanomaterial on the surface of and within the solid porous material.

Articles including a solid porous material having a selenium nanomaterial bound to a surface of and within the solid porous material. The article may be a include no polymeric stabilizer or proteinaceous stabilizer. The solid porous material may be a sponge, a film, a fabric, a non-woven material, or a metal-organic framework (MOF), or a combination thereof. The article may be produced by treating a solid porous material with an aqueous selenous acid solution and heating the solid porous material to form the selenium nanomaterial on the surface of and within the solid porous material.

Articles including a solid porous material having a selenium nanomaterial bound to a surface of and within the solid porous material. The article may be a include no polymeric stabilizer or proteinaceous stabilizer. The solid porous material may be a sponge, a film, a fabric, a non-woven material, or a metal-organic framework (MOF), or a combination thereof. The article may be produced by treating a solid porous material with an aqueous selenous acid solution and heating the solid porous material to form the selenium nanomaterial on the surface of and within the solid porous material.

A process for sanitizing one or more target medical personal protective equipment units, the method that includes the step of contacting the target medical personal protective equipment unit with a charge solution for a contact interval, the contact interval sufficient to infiltrate surfaces located in the interior of the one or more target medical personal protective equipment units. The charge solution includes a polar solvent and an active compound having the chemical formula:

[00001]$.Math.H_x{O}_{\frac{\left(x-1\right)}{2}}.Math.Z_y$ wherein x is an odd integer ≥3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 and 17 having a charge value between −1 and −3 or a polyatomic ion having a charge between −1 and −3.

A process for sanitizing one or more target medical personal protective equipment units, the method that includes the step of contacting the target medical personal protective equipment unit with a charge solution for a contact interval, the contact interval sufficient to infiltrate surfaces located in the interior of the one or more target medical personal protective equipment units. The charge solution includes a polar solvent and an active compound having the chemical formula:

[00001]$.Math.H_x{O}_{\frac{\left(x-1\right)}{2}}.Math.Z_y$ wherein x is an odd integer ≥3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 and 17 having a charge value between −1 and −3 or a polyatomic ion having a charge between −1 and −3.

Presented here is a multi-functional powder which: comprises the first component that includes one selection from the group consisting of silicon oxide (SiO2), aluminum oxide (Al2O3), calcium oxide (CaO), magnesium oxide (MgO), and combinations thereof; and the second component that includes at least one selection from the group consisting of iron oxide (Fe2O3), potassium oxide (K2O), sodium oxide (Na2O), strontium oxide (SrO), sulfur trioxide (S3O), boron oxide (B2O3), manganese oxide (MnO), titanium dioxide (TiO2), and combinations thereof; whose far-infrared emission rate for the wavelength region of 5 .Math.ms to 20 .Math.ms at 37° C. is between 0.5% and 5%; whose harmful gas deodorization balance index under the following Formula 1 is between 0.8 and 2.0; and whose bacterial reduction rate (%) is 90% or greater for each of staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 8739), Klebsiella pneumonia (ATCC 4352), and Pseudomonas aeruginosa (ATCC 10145).